Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 172 of the 176 references it cites were found in a registry or an index.

Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials–Process Perspective

Open access

Abstract

Three dimensional (3D) printing as an advanced manufacturing technology is progressing to be established in the pharmaceutical industry to overcome the traditional manufacturing regime of 'one size fits for all'. Using 3D printing, it is possible to design and develop complex dosage forms that can be suitable for tuning drug release. Polymers are the key materials that are necessary for 3D printing. Among all 3D printing processes, extrusion-based (both fused deposition modeling (FDM) and pressure-assisted microsyringe (PAM)) 3D printing is well researched for pharmaceutical manufacturing. It is important to understand which polymers are suitable for extrusion-based 3D printing of pharmaceuticals and how their properties, as well as the behavior of polymer–active pharmaceutical ingredient (API) combinations, impact the printing process. Especially, understanding the rheology of the polymer and API–polymer mixtures is necessary for successful 3D printing of dosage forms or printed structures. This review has summarized a holistic materials–process perspective for polymers on extrusion-based 3D printing. The main focus herein will be both FDM and PAM 3D printing processes. It elaborates the discussion on the comparison of 3D printing with the traditional direct compression process, the necessity of rheology, and the characterization techniques required for the printed structure, drug, and excipients. The current technological challenges, regulatory aspects, and the direction toward which the technology is moving, especially for personalized pharmaceuticals and multi-drug printing, are also briefly discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pharmaceutics12020124

Cites

172 of 172 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (a) The proportion of research articles published on different types of 3D printing processes in the last five years (2015-2019, total 202 articles); (b) The number of published scientific articles (research and review) in the period from 2015 to 2019 which reported the use of extrusion-based (fused deposition modeling (FDM) or pressure-assisted microsyringe (PAM)) 3D printing (source: Scopus database and PubMed).
Figure 1 (a) The proportion of research articles published on different types of 3D printing processes in the last five years (2015-2019, total 202 articles); (b) The number of published scientific articles (research and review) in the period from 2015 to 2019 which reported the use of extrusion-based (fused deposition modeling (FDM) or pressure-assisted microsyringe (PAM)) 3D printing (source: Scopus database and PubMed).CC BY · PubMed Central
Figure 2 2-dimensional (2D) schematic of the extrusion-based 3D printing process: (a) fused deposition modeling (FDM), (b) pressure-assisted microsyringe (PAM).
Figure 2 2-dimensional (2D) schematic of the extrusion-based 3D printing process: (a) fused deposition modeling (FDM), (b) pressure-assisted microsyringe (PAM).CC BY · PubMed Central
Figure 3 Workflow diagram or decision matrix for a 3D printing process. (CAD: computer-aided design, FDM: fused deposition modeling, PAM: pressure-assisted microsyringe, NIH 3D PE: National Institutes of Health 3D Print Exchange).
Figure 3 Workflow diagram or decision matrix for a 3D printing process. (CAD: computer-aided design, FDM: fused deposition modeling, PAM: pressure-assisted microsyringe, NIH 3D PE: National Institutes of Health 3D Print Exchange).CC BY · PubMed Central
Figure 4 Comparison of different processing steps required for traditional direct compression (DC) tablet manufacturing vs. advanced manufacturing, 3D printing (FDM or PAM).
Figure 4 Comparison of different processing steps required for traditional direct compression (DC) tablet manufacturing vs. advanced manufacturing, 3D printing (FDM or PAM).CC BY · PubMed Central
Figure 5 Summary of polymers based on (a) water solubility and drug release type, (b) their selection for either FDM or PAM 3D printing method.
Figure 5 Summary of polymers based on (a) water solubility and drug release type, (b) their selection for either FDM or PAM 3D printing method.CC BY · PubMed Central
Figure 6 Important rheological tests are required for polymer–drug paste or molten dispersions to ensure their suitability and processability for extrusion-based (FDM, PAM) 3D printing.
Figure 6 Important rheological tests are required for polymer–drug paste or molten dispersions to ensure their suitability and processability for extrusion-based (FDM, PAM) 3D printing.CC BY · PubMed Central
Figure 7 Viscosity ratio (η/ηo) of acetaminophen (APAP) in poly (ethylene oxide) (PEO) at different temperatures to determine the solubility of the drug. Reprinted with permission from M Yang, International Journal of Pharmaceutics, Published by Elsevier, 2011 [123].
Figure 7 Viscosity ratio (η/ηo) of acetaminophen (APAP) in poly (ethylene oxide) (PEO) at different temperatures to determine the solubility of the drug. Reprinted with permission from M Yang, International Journal of Pharmaceutics, Published by Elsevier, 2011 [123].CC BY · PubMed Central
Figure 8 The rheological characterization of the blends of different polymers [Affinisol 15LV (Aff15), Kollidon SR (KollSR), Eudragit EPO (EPO), hydroxypropyl cellulose (HPC)]. Constituent effect visualized with frequency sweep at the maximum processing temperature (200 °C). Reprinted with permission from K Ilyés, European Journal of Pharmaceutical Sciences, Published by Elsevier, 2019 [136].
Figure 8 The rheological characterization of the blends of different polymers [Affinisol 15LV (Aff15), Kollidon SR (KollSR), Eudragit EPO (EPO), hydroxypropyl cellulose (HPC)]. Constituent effect visualized with frequency sweep at the maximum processing temperature (200 °C). Reprinted with permission from K Ilyés, European Journal of Pharmaceutical Sciences, Published by Elsevier, 2019 [136].CC BY · PubMed Central
Figure 9 Characterizations required for 3D printed structure, drug, and polymer (or other functional excipients, if necessary).
Figure 9 Characterizations required for 3D printed structure, drug, and polymer (or other functional excipients, if necessary).CC BY · PubMed Central
Figure 10 (a) Design of tablets, (b) the relationship between the target and achieved prednisolone dose, and (c) PVA based FDM 3D printed tablets having different dose strengths [56].
Figure 10 (a) Design of tablets, (b) the relationship between the target and achieved prednisolone dose, and (c) PVA based FDM 3D printed tablets having different dose strengths [56].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 176 references

Research works printed but not linked: 3

  1. Hardung, 2010, Combining HME & solubilization: Soluplus®—The solid solution, Drug Deliv. Technol., 10, 20
  2. Aho, J., Genina, N., Edinger, M., Botker, J.P., Baldursdottir, S., and Rantanen, J. (June, January 30). Drug-loaded poly (ε-caprolactone) for 3D printing of personalized medicine: A rheological study. Proceedings of the 25th Nordic Rheology Conference, Helsinki, Finland.
  3. Campbell, 2017, Pharma to table: 3-D printing and the regulatory future of home remedies, Conn. L. Rev. CONNtemplations, 49, 1

Cited by

See all 356

Metadata

Authors
Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T.
Affiliations
  • North Carolina Agricultural and Technical State University (US)
  • Virginia Commonwealth University (US)
  • City University of New York (US)
  • Massachusetts College of Pharmacy and Health Sciences (US)
Corresponding author
Azad, Mohammad A.
Venue
Pharmaceutics
Publisher
MDPI AG
Published
2020-02-03
Volume
12
Issue
2
Pages
124
ISSN
1999-4923 (ISSN-L)
OpenAlex
W3003558240
Cited by
356
References
176
Citations by year
2026: 38 · 2025: 44 · 2024: 48 · 2023: 73 · 2022: 66 · 2021: 57 · 2020: 28
FWCI
3.89
Type
journal article
Language
en
Open access
Locations
  • Pharmaceutics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • CUNY Academic Works (City University of New York) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Physical Sciences › Engineering › Industrial and Manufacturing Engineering › Additive Manufacturing and 3D Printing Technologies
  • Physical Sciences › Engineering › Building and Construction › Innovations in Concrete and Construction Materials
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
material extrusion, pharmaceutical 3D printing, fused deposition modeling, polymer rheology, controlled drug release

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials–Process Perspective. https://app.cochat.ai/papers/10.3390/pharmaceutics12020124
The paper
Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T. (2020). Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials–Process Perspective. Pharmaceutics. https://doi.org/10.3390/pharmaceutics12020124

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.